Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024
Compare Balance Sheet Results of Jagsonpal Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.28
8.51
4.77
56.05%
Share Warrants & Outstandings
Total Reserve
204.71
330.58
-125.87
-38.08%
Shareholder's Funds
239.95
339.09
-99.14
-29.24%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
51.31
-51.31
-100.00%
Secured Loans
0.00
51.31
-51.31
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
3.07
5.73
-2.66
-46.42%
Other Long Term Liabilities
8.30
50.78
-42.48
-83.65%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.04
2.38
-1.34
-56.30%
Total Non-Current Liabilities
12.41
110.21
-97.80
-88.74%
Current Liabilities
Trade Payables
9.73
32.53
-22.80
-70.09%
Other Current Liabilities
15.16
10.29
4.87
47.33%
Short Term Borrowings
0.00
52.95
-52.95
-100.00%
Short Term Provisions
1.01
0.92
0.09
9.78%
Total Current Liabilities
25.90
96.70
-70.80
-73.22%
Total Liabilities
278.26
546.00
-267.74
-49.04%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
93.47
212.38
-118.91
-55.99%
Less: Accumulated Depreciation
7.25
106.92
-99.67
-93.22%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
86.23
105.46
-19.23
-18.23%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
176.67
-176.67
-100.00%
Intangible assets under development
0.00
6.03
-6.03
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
64.69
-64.69
-100.00%
Long Term Loans & Advances
1.33
6.30
-4.97
-78.89%
Other Non Current Assets
21.29
1.61
19.68
1,222.36%
Total Non-Current Assets
117.07
360.76
-243.69
-67.55%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
15.20
58.51
-43.31
-74.02%
Sundry Debtors
13.18
80.59
-67.41
-83.65%
Cash and Bank
128.73
2.18
126.55
5,805.05%
Other Current Assets
1.66
3.93
-2.27
-57.76%
Short Term Loans and Advances
2.42
40.02
-37.60
-93.95%
Total Current Assets
161.19
185.24
-24.05
-12.98%
Net Current Assets (Including Current Investments)
135.29
88.53
46.76
52.82%
Total Current Assets Excluding Current Investments
161.19
185.24
-24.05
-12.98%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
278.26
546.00
-267.74
-49.04%
Contingent Liabilities
16.17
119.67
-103.50
-86.49%
Total Debt
0.00
104.27
-104.27
-100.00%
Book Value per share (adjusted)
36.08
398.60
-362.52
-90.95%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 8.30 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 86.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Current Assets
Current Assets 161.19 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024






